Total planned funding: $192,693,481

Clear active filters Zimbabwe Treatment HTXD: Treatment: ARV Drugs 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2020

Allocations

Countries/Regions

$192,693,481

Organizational Types

Private Contractor	$190,847,597
Unknown	$1,735,843
Own Agency	$110,041
NGO	$0
FBO	$0
Multi-lateral Agency	$0
University	$0
Other USG Agency	$0
Implementing Agency	$0

Program Areas

$192,693,481

Budget Codes

HTXD: Treatment: ARV Drugs

$192,693,481

Top Partner Programs

Partnership for Supply Chain Management:
$108,689,482

Countries/Regions

Zimbabwe

2008	$7,230,000
2009	$4,000,000
2010	$5,625,000
2011	$9,870,400
2012	$20,336,400
2013	$19,684,038
2014	$19,971,822
2015	$21,971,822

Chemonics International:
$82,158,115

Countries/Regions

Zimbabwe

2016	$21,971,822
2017	$20,029,673
2018	$21,411,062
2020	$18,745,558

Not Available:
$1,735,843

Countries/Regions

Zimbabwe

2006	$900,000
2007	$825,000
2012	$10,843
2018	$0

U.S. Agency for International Development:
$106,350

Countries/Regions

Zimbabwe

2009	$58,889
2013	$5,310
2014	$42,151

U.S. Centers for Disease Control and Prevention:
$3,691

Countries/Regions

Zimbabwe

$3,691